Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 309

1.

Predicting Thrombocytopenia in Patients With Breast Cancer Treated With Ado-trastuzumab Emtansine.

Modi ND, Sorich MJ, Rowland A, McKinnon RA, Koczwara B, Wiese MD, Hopkins AM.

Clin Breast Cancer. 2019 Dec 7. pii: S1526-8209(19)30715-3. doi: 10.1016/j.clbc.2019.10.001. [Epub ahead of print]

PMID:
31892489
2.

Profiling of Drug-Metabolizing Enzymes and Transporters in Human Tissue Biopsy Samples; A Review of the Literature.

Rodrigues AD, Rowland A.

J Pharmacol Exp Ther. 2019 Dec 26. pii: jpet.119.262972. doi: 10.1124/jpet.119.262972. [Epub ahead of print]

3.

Induction of Human Intestinal and Hepatic Organic Anion Transporting Polypeptides; Where is the Evidence for its Relevance in Drug-Drug Interactions?

Rodrigues AD, Lai Y, Shen H, Varma MVS, Rowland A, Oswald S.

Drug Metab Dispos. 2019 Dec 26. pii: dmd.119.089615. doi: 10.1124/dmd.119.089615. [Epub ahead of print]

4.

Association Between Body Mass Index and Overall Survival With Immune Checkpoint Inhibitor Therapy for Advanced Non-Small Cell Lung Cancer.

Kichenadasse G, Miners JO, Mangoni AA, Rowland A, Hopkins AM, Sorich MJ.

JAMA Oncol. 2019 Dec 26. doi: 10.1001/jamaoncol.2019.5241. [Epub ahead of print]

PMID:
31876896
5.

Relationship between vemurafenib plasma concentrations and survival outcomes in patients with advanced melanoma.

Kichenadasse G, Hughes JH, Miners JO, Mangoni AA, Rowland A, Hopkins AM, Sorich MJ.

Cancer Chemother Pharmacol. 2019 Nov 30. doi: 10.1007/s00280-019-04002-1. [Epub ahead of print]

PMID:
31786653
6.

Baseline tumor size and survival outcomes in lung cancer patients treated with immune checkpoint inhibitors.

Hopkins AM, Kichenadasse G, McKinnon RA, Rowland A, Sorich MJ.

Semin Oncol. 2019 Aug - Oct;46(4-5):380-384. doi: 10.1053/j.seminoncol.2019.10.002. Epub 2019 Nov 6.

PMID:
31735362
7.

Guidelines on suicide amongst anaesthetists 2019.

Shinde S, Yentis SM, Asanati K, Coetzee RH, Cole-King A, Gerada C, Harding K, Hawton K, Hennessy A, Keats P, Kumar N, McGlennan A, Pappenheim K, Plunkett E, Prior K, Rowland A.

Anaesthesia. 2020 Jan;75(1):96-108. doi: 10.1111/anae.14890. Epub 2019 Nov 14.

PMID:
31729019
8.

Effect of Early Adverse Events on Survival Outcomes of Patients with Metastatic Colorectal Cancer Treated with Ramucirumab.

Lim HH, Hopkins AM, Rowland A, Yuen HY, Karapetis CS, Sorich MJ.

Target Oncol. 2019 Dec;14(6):743-748. doi: 10.1007/s11523-019-00683-z.

PMID:
31676953
9.

Fine balance between pragmatism and rigidness in system approaches to acute care.

Roland DT, Rowland A, Cotterill S, Heal C, Woby S, Garratt N, Brown S, Long T.

BMJ. 2019 Oct 31;367:l6226. doi: 10.1136/bmj.l6226. No abstract available.

PMID:
31672912
10.

Validation of a 3-h Sampling Interval to Assess Variability in Cytochrome P450 3A Phenotype and the Impact of Induction and Mechanism-Based Inhibition Using Midazolam as a Probe Substrate.

van Dyk M, Kapetas AJ, Hopkins AM, Rodrigues AD, Vourvahis M, Sorich MJ, Rowland A.

Front Pharmacol. 2019 Sep 27;10:1120. doi: 10.3389/fphar.2019.01120. eCollection 2019.

11.

Prognostic model of survival outcomes in non-small cell lung cancer patients initiated on afatinib: pooled analysis of clinical trial data.

Hopkins AM, Shahnam A, Zhang S, Karapetis CS, Rowland A, Sorich MJ.

Cancer Biol Med. 2019 May;16(2):341-349. doi: 10.20892/j.issn.2095-3941.2018.0474.

12.

Predictors of Long-Term Disease Control and Survival for HER2-Positive Advanced Breast Cancer Patients Treated With Pertuzumab, Trastuzumab, and Docetaxel.

Hopkins AM, Rowland A, McKinnon RA, Sorich MJ.

Front Oncol. 2019 Aug 22;9:789. doi: 10.3389/fonc.2019.00789. eCollection 2019.

13.

Author's Reply.

Sorich MJ, Rowland A, Karapetis CS, Hopkins AM.

J Thorac Oncol. 2019 Sep;14(9):e210. doi: 10.1016/j.jtho.2019.07.009. No abstract available.

PMID:
31445742
14.

Response to the Letter to the Editor: Lung Immune Prognostic Index for Outcome Prediction to Immunotherapy in Patients With NSCLC.

Sorich MJ, Rowland A, Karapetis CS, Hopkins AM.

J Thorac Oncol. 2019 Sep;14(9):e208. doi: 10.1016/j.jtho.2019.05.035. Epub 2019 Jun 7. No abstract available.

PMID:
31445740
15.

Inhibition of human UDP-glucuronosyltransferase (UGT) enzymes by kinase inhibitors: Effects of dabrafenib, ibrutinib, nintedanib, trametinib and BIBF 1202.

Korprasertthaworn P, Chau N, Nair PC, Rowland A, Miners JO.

Biochem Pharmacol. 2019 Nov;169:113616. doi: 10.1016/j.bcp.2019.08.018. Epub 2019 Aug 22.

PMID:
31445021
16.

Validation of dabrafenib-trametinib prognostic groups in patients treated with vemurafenib and cobimetinib for advanced BRAF-mutated melanoma.

Sorich MJ, Rowland A, Hopkins AM.

Melanoma Res. 2019 Aug 14. doi: 10.1097/CMR.0000000000000634. [Epub ahead of print]

PMID:
31425480
17.

The association between maternal interaction and infant cortisol stress reactivity among preterm and full term infants at 4 months adjusted age.

Erickson SJ, Kubinec N, Vaccaro S, Moss N, Rieger R, Rowland A, Lowe JR.

Infant Behav Dev. 2019 Nov;57:101342. doi: 10.1016/j.infbeh.2019.101342. Epub 2019 Aug 14.

PMID:
31421390
18.

Clinical outcomes of combined surgical treatment of medial epicondylitis and cubital tunnel syndrome.

Mooney M, Andrews K, Rowland A, Jain M, Mustapha AA, Skie M.

Hand Surg Rehabil. 2019 Oct;38(5):298-301. doi: 10.1016/j.hansur.2019.08.001. Epub 2019 Aug 9.

PMID:
31404681
19.

Effect of early adverse events resulting in ado-trastuzumab emtansine dose adjustments on survival outcomes of HER2+ advanced breast cancer patients.

Tang E, Rowland A, McKinnon RA, Sorich MJ, Hopkins AM.

Breast Cancer Res Treat. 2019 Nov;178(2):473-477. doi: 10.1007/s10549-019-05393-8. Epub 2019 Aug 9.

PMID:
31399933
20.

Defining and Measuring Students' Interest in Biology: An Analysis of the Biology Education Literature.

Rowland AA, Knekta E, Eddy S, Corwin LA.

CBE Life Sci Educ. 2019 Sep;18(3):ar34. doi: 10.1187/cbe.19-02-0037.

21.

Guidance for Rifampin and Midazolam Dosing Protocols To Study Intestinal and Hepatic Cytochrome P450 (CYP) 3A4 Induction and De-induction.

Kapetas AJ, Sorich MJ, Rodrigues AD, Rowland A.

AAPS J. 2019 Jun 19;21(5):78. doi: 10.1208/s12248-019-0341-y.

PMID:
31218462
22.

Primary predictors of survival outcomes for HER2-positive advanced breast cancer patients initiating ado-trastuzumab emtansine.

Hopkins AM, Rowland A, Logan JM, Sorich MJ.

Breast. 2019 Aug;46:90-94. doi: 10.1016/j.breast.2019.05.011. Epub 2019 May 11.

PMID:
31170589
23.

Identification of the caffeine to trimethyluric acid ratio as a dietary biomarker to characterise variability in cytochrome P450 3A activity.

van Dyk M, Miners JO, Marshall JC, Wood LS, Hopkins A, Sorich MJ, Rowland A.

Eur J Clin Pharmacol. 2019 Sep;75(9):1211-1218. doi: 10.1007/s00228-019-02682-5. Epub 2019 May 23.

PMID:
31123759
24.

Fracture of allograft interbody spacer resulting in post-operative radiculopathy: A case report.

Kyle A, Rowland A, Stirton J, Elgafy H.

World J Orthop. 2019 Apr 18;10(4):206-211. doi: 10.5312/wjo.v10.i4.206. eCollection 2019 Apr 18.

25.

Evaluation of the Lung Immune Prognostic Index for Prediction of Survival and Response in Patients Treated With Atezolizumab for NSCLC: Pooled Analysis of Clinical Trials.

Sorich MJ, Rowland A, Karapetis CS, Hopkins AM.

J Thorac Oncol. 2019 Aug;14(8):1440-1446. doi: 10.1016/j.jtho.2019.04.006. Epub 2019 Apr 15.

PMID:
30999110
26.

Knee locked in flexion: incarcerated semitendinosus tendon around a proximal tibial osteochondroma.

Andrews K, Rowland A, Tank J.

J Surg Case Rep. 2019 Feb 8;2019(2):rjy346. doi: 10.1093/jscr/rjy346. eCollection 2019 Feb.

27.

Effect of early adverse events on response and survival outcomes of advanced melanoma patients treated with vemurafenib or vemurafenib plus cobimetinib: A pooled analysis of clinical trial data.

Hopkins AM, Van Dyk M, Rowland A, Sorich MJ.

Pigment Cell Melanoma Res. 2019 Jul;32(4):576-583. doi: 10.1111/pcmr.12773. Epub 2019 Feb 28.

PMID:
30758912
28.

The UDP-Glycosyltransferase (UGT) Superfamily: New Members, New Functions, and Novel Paradigms.

Meech R, Hu DG, McKinnon RA, Mubarokah SN, Haines AZ, Nair PC, Rowland A, Mackenzie PI.

Physiol Rev. 2019 Apr 1;99(2):1153-1222. doi: 10.1152/physrev.00058.2017. Review.

PMID:
30724669
29.

A retrospective cohort study of racing performance in Quarter Horses undergoing prosthetic laryngoplasty for treatment of recurrent laryngeal neuropathy.

Krueger CR, Lewis RD, McIlwraith CW, Major MD, Brakenhoff JE, Hand DR, Rowland AL, Hess AM, Johnson SW, Hackett ES.

J Am Vet Med Assoc. 2019 Feb 15;254(4):496-500. doi: 10.2460/javma.254.4.496.

PMID:
30714865
30.

Use of Physiologically Based Pharmacokinetic Modeling to Identify Physiological and Molecular Characteristics Driving Variability in Axitinib Exposure: A Fresh Approach to Precision Dosing in Oncology.

Sorich MJ, Mutlib F, van Dyk M, Hopkins AM, Polasek TM, Marshall JC, Rodrigues AD, Rowland A.

J Clin Pharmacol. 2019 Jun;59(6):872-879. doi: 10.1002/jcph.1377. Epub 2019 Jan 11.

PMID:
30633368
32.

Toward Dynamic Prescribing Information: Codevelopment of Companion Model-Informed Precision Dosing Tools in Drug Development.

Polasek TM, Rayner CR, Peck RW, Rowland A, Kimko H, Rostami-Hodjegan A.

Clin Pharmacol Drug Dev. 2019 May;8(4):418-425. doi: 10.1002/cpdd.638. Epub 2018 Nov 30.

PMID:
30500115
33.

Students Who Fail to Achieve Predefined Research Goals May Still Experience Many Positive Outcomes as a Result of CURE Participation.

Gin LE, Rowland AA, Steinwand B, Bruno J, Corwin LA.

CBE Life Sci Educ. 2018 Dec;17(4):ar57. doi: 10.1187/cbe.18-03-0036.

34.

In vitro MSC function is related to clinical reaction in vivo.

Rowland AL, Xu JJ, Joswig AJ, Gregory CA, Antczak DF, Cummings KJ, Watts AE.

Stem Cell Res Ther. 2018 Nov 8;9(1):295. doi: 10.1186/s13287-018-1037-4.

35.

Plasma extracellular nanovesicle (exosome)-derived biomarkers for drug metabolism pathways: a novel approach to characterize variability in drug exposure.

Rowland A, Ruanglertboon W, van Dyk M, Wijayakumara D, Wood LS, Meech R, Mackenzie PI, Rodrigues AD, Marshall JC, Sorich MJ.

Br J Clin Pharmacol. 2019 Jan;85(1):216-226. doi: 10.1111/bcp.13793. Epub 2018 Nov 16.

36.

Bone Marrow Aspiration Does Not Induce a Measurable Pain Response Compared to Sham Procedure.

Rowland AL, Navas de Solis C, Lepiz MA, Cummings KJ, Watts AE.

Front Vet Sci. 2018 Oct 1;5:233. doi: 10.3389/fvets.2018.00233. eCollection 2018.

37.

Risk Factors for Severe Diarrhea with an Afatinib Treatment of Non-Small Cell Lung Cancer: A Pooled Analysis of Clinical Trials.

Hopkins AM, Nguyen AM, Karapetis CS, Rowland A, Sorich MJ.

Cancers (Basel). 2018 Oct 15;10(10). pii: E384. doi: 10.3390/cancers10100384.

38.

Defining significant childhood illness and injury in the Emergency Department: a consensus of UK and Ireland expert opinion.

Lillitos PJ, Lyttle MD, Roland D, Powell CV, Sandell J, Rowland AG, Chapman SM, Maconochie IK; PERUKI and GAPRUKI.

Emerg Med J. 2018 Nov;35(11):685-690. doi: 10.1136/emermed-2018-207802. Epub 2018 Oct 3.

39.

Data sharing from pharmaceutical industry sponsored clinical studies: audit of data availability.

Hopkins AM, Rowland A, Sorich MJ.

BMC Med. 2018 Sep 28;16(1):165. doi: 10.1186/s12916-018-1154-z.

40.
41.

Cubital tunnel syndrome: Anatomy, clinical presentation, and management.

Andrews K, Rowland A, Pranjal A, Ebraheim N.

J Orthop. 2018 Aug 16;15(3):832-836. doi: 10.1016/j.jor.2018.08.010. eCollection 2018 Sep. Review.

42.

Rowland et al. Respond.

Rowland AS, Gorman SA, Thoma RJ, Annett RA, McGrew CA, Yeo RA, Mayer AR, King JH, Campbell RA.

Am J Public Health. 2018 Jul;108(7):e12-e13. doi: 10.2105/AJPH.2018.304443. No abstract available.

43.

Influence of caudal epidural analgesia on cortisol concentrations and pain-related behavioral responses in mares during and after ovariectomy via colpotomy.

Rowland AL, Glass KG, Grady ST, Cummings KJ, Hinrichs K, Watts AE.

Vet Surg. 2018 Jul;47(5):715-721. doi: 10.1111/vsu.12908. Epub 2018 May 18.

PMID:
29774961
44.

Physiologically Based Pharmacokinetic Modeling to Identify Physiological and Molecular Characteristics Driving Variability in Drug Exposure.

Rowland A, van Dyk M, Hopkins AM, Mounzer R, Polasek TM, Rostami-Hodjegan A, Sorich MJ.

Clin Pharmacol Ther. 2018 Dec;104(6):1219-1228. doi: 10.1002/cpt.1076. Epub 2018 Apr 19.

PMID:
29574693
45.

Assessment of inter-racial variability in CYP3A4 activity and inducibility among healthy adult males of Caucasian and South Asian ancestries.

van Dyk M, Marshall JC, Sorich MJ, Wood LS, Rowland A.

Eur J Clin Pharmacol. 2018 Jul;74(7):913-920. doi: 10.1007/s00228-018-2450-4. Epub 2018 Mar 23.

PMID:
29572563
46.

Food safety evaluation for R-proteins introduced by biotechnology: A case study of VNT1 in late blight protected potatoes.

Habig JW, Rowland A, Pence MG, Zhong CX.

Regul Toxicol Pharmacol. 2018 Jun;95:66-74. doi: 10.1016/j.yrtph.2018.03.008. Epub 2018 Mar 9. Review.

PMID:
29530614
47.

Predictors of anti-VEGF drug-induced hypertension using different hypertension criteria: a secondary analysis of the COMPARZ study.

Mangoni AA, Kichenadasse G, Rowland A, Sorich MJ.

Ther Adv Med Oncol. 2018 Feb 5;10:1758834018755090. doi: 10.1177/1758834018755090. eCollection 2018.

48.

Balancing Public Protection with Fairness to Doctors.

Rowland A.

Med Leg J. 2018 Jun;86(2):72-80. doi: 10.1177/0025817217752876. Epub 2018 Jan 8. No abstract available.

PMID:
29308972
49.

Prediction of olanzapine exposure in individual patients using physiologically based pharmacokinetic modelling and simulation.

Polasek TM, Tucker GT, Sorich MJ, Wiese MD, Mohan T, Rostami-Hodjegan A, Korprasertthaworn P, Perera V, Rowland A.

Br J Clin Pharmacol. 2018 Mar;84(3):462-476. doi: 10.1111/bcp.13480. Epub 2018 Jan 11.

50.

Evaluation of modafinil as a perpetrator of metabolic drug-drug interactions using a model informed cocktail reaction phenotyping trial protocol.

Rowland A, van Dyk M, Warncken D, Mangoni AA, Sorich MJ, Rowland A.

Br J Clin Pharmacol. 2018 Mar;84(3):501-509. doi: 10.1111/bcp.13478. Epub 2018 Jan 10.

Supplemental Content

Loading ...
Support Center